Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

4.235 +0.125 (+3.04%)
Streaming Delayed Price Updated: 1:01 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Savara Added to Russell 3000® Index
From Savara Inc.
Via Business Wire
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
From Savara Inc.
Via Business Wire
Why Shares of Savara Soared This Week
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases. 
Via The Motley Fool
Savara to Present at the Jefferies Healthcare Conference
From Savara Inc.
Via Business Wire
Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Why Shares of Savara Jumped on Tuesday
The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy. 
Via The Motley Fool
Savara Reports First Quarter Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
 
Via Benzinga
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Savara Announces New Leadership Appointments
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Participate in Three Upcoming Investor Conferences
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
From Savara Inc.
Via Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
From Savara Inc.
Via Business Wire
Savara Announces Resignation of Chief Medical Officer
From Savara Inc.
Via Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
From Savara Inc.
Via Business Wire
Recap: Savara Q2 Earnings
  Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of... 
Via Benzinga
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
From Savara Inc.
Via Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
From Savara Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.